Unlocking the Secrets of Endometriosis: A New Look at Immune Factors

Endometriosis, a common chronic inflammatory condition among women before menopause, is characterized by the abnormal growth of endometrial tissue outside the uterus, frequently affecting the ovaries. While this tissue isn't cancerous, it shares many traits with malignant tumors, like an altered immune environment, specific hormone levels, high oxidative stress, chronic inflammation, and irregular immune cell activity. The exact cause of endometriosis remains mysterious, complicating the search for early diagnostic markers and effective treatments.

Over recent decades, there's been significant progress. Researchers are now focusing on immune-related factors in the misplaced endometrial tissue to uncover biomarkers and potential therapeutic targets. This includes the roles of natural killer cells, macrophages, the complement system, miRNA, and P-selectin. The goal is to discover accurate diagnostic tools and develop personalized immune-targeted therapies for endometriosis.

Actions